Current Assets

Derivatives

Biogen Derivatives increased by 91.0% to $19.10M in Q1 2026 compared to the prior quarter.

Analysis

StatementBalance Sheet Statement
SectionCurrent Assets
CategoryRisk
SignalContext dependent
VolatilityVolatile
First reportedQ4 2020
Last reportedQ3 2025

How to read this metric

An increase indicates favorable market movements in hedged positions, while a decrease reflects unfavorable movements or contract settlements.

Detailed definition

The fair value of derivative financial instruments that are expected to be settled within one year and result in a net a...

Peer comparison

Standard for energy companies utilizing hedging strategies to manage commodity price volatility.

Metric ID: current_assets_derivative_assets_current

Historical Data

2 periods
 Q4 '25Q1 '26
Value$10.00M$19.10M
QoQ Change+91.0%
Range$10.00M$19.10M

Derivatives at Other Companies

Frequently Asked Questions

What is Biogen's derivatives?
Biogen (BIIB) reported derivatives of $19.10M in Q1 2026.
What does derivatives mean?
The current value of financial contracts that are expected to provide a future economic benefit.